| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.038 | 0.5 |